~" The authors present a retrospective analysis of the management of deep vein thrombosis (DVT) and pulmonary embolism (PE) in neurosurgical patients at the Massachusetts General Hospital from January, 1978, through June, 1982. There were 44 cases of DVT and 13 cases of PE. Management modalities included observation only, femoral vein ligation, inferior vena cava clipping, transvenous placement of an inferior vena cava filter or umbrella, and anticoagulation therapy. Six (75%) of eight patients with symptomatic DVT who were managed by observation alone had subsequent pulmonary emboli, and three (38%) died. Femoral vein ligation was followed by PE in one of four cases and led to significant leg swelling in two others. Neither observation alone nor femoral vein ligation can be recommended as routine management options. Partial inferior vena cava interruption with a De Weese clip, Kim-Ray Greenfield filter, or Mobin-Uddin umbrella all successfully prevented pulmonary emboli. The major problem associated with these methods was leg edema, which occurred in 47% of patients with clip placement, 25% with filter placement, and 21% with a MobinUddin umbrella. Anticoagulation therapy was associated with a complication rate of 29% and a mortality rate of 15 %. Fatal PE and paradoxical hypercoagulability with gangrene of a lower extremity were the causes of death. In one patient, hemorrhage into a glioblastoma occurred following discontinuation of anticoagulation therapy when the coagulation parameters were normal.
N
EUROSURGICAL patients are often at risk for the development of deep vein thrombosis (DVT) of the lower extremity and/or pulmonary embolism (PE) due to prolonged surgery, immobilization, paralysis, advanced age, and malignancy. 7'23 Deep vein thrombosis is reported to occur in 29% to 43% of neurosurgical patients) 4'25 While the incidence of PE has not recently been analyzed in neurosurgical patients, Wetzel, et al., 28 have implicated this event in 3% of neurosurgical deaths.
Management of DVT and PE in neurosurgical patients can be problematic because of the potential for central nervous system hemorrhage resulting from standard anticoagulation therapy. Concern for the possibility of such disastrous complications has generally led our service to use methods of arresting emboli at the inferior vena cava (IVC) by use of an IVC clip, umbrella, or filter. This report reviews our cumulative experience in the management of DVT and PE on the Massachusetts General Hospital (MGH) neurosurgical service from 1978 through 1982.
Clinical Material and Methods
The hospital records of patients reported to have DVT or PE on the MGH neurosurgical service from January, 1978, through June, 1982, were reviewed. The patients' age, sex, primary neurological diagnosis, mode of therapy, and subsequent complications were noted. Patients were selected for this study if they: l) had leg swelling and/or pain symptomatic of DVT, or chest pain or shortness of breath symptomatic of PE, and 2) ~f Clipping not possible because of retroperitoneal bleeding.
had DVT documented by venography or PE proven by pulmonary angiography or autopsy. In the 54-month period of the study, there were 44 cases of DVT and 13 of PE. Anticoagulation was accomplished with heparin given as a 5000-U intravenous bolus, followed by continuous infusion of approximately 1000 U/hr, adjusted to maintain the partial thromboplastin time (PTT) at two to two and one-half times the control value. Oral anticoagulation with Coumadin (sodium warfarin) was initiated after 3 to 5 days of heparin therapy. Heparin was continued until the Coumadin elevated the prothrombin time to approximately one and one-half times the control level.
Partial interruption of the IVC was achieved with one of the following methods: l) an Adams-De Weese clip ~ placed via laparotomy; 2) a Kim-Ray Greenfield filter inserted transvenously; 11 or 3) a Mobin-Uddin umbrella inserted transvenously. 17 Femoral vein ligation was achieved by local femoral cutdown) 2
Summary of Cases

Deep Vein Thrombosis
Seventeen patients with DVT were managed either with interruption of the involved femoral vein (four cases) or with placement of a De Weese clip on the IVC (13 cases) ( third patient required IVC clipping because pulmonary emboli occurred despite the femoral ligation. Five (38%) of the 13 patients with IVC clipping had postoperative leg edema; in one (Case 17), gangrene developed in the foot necessitating amputation.
Fourteen patients with DVT were treated with either a Kim-Ray Greenfield filter or a Mobin-Uddin umbrella (Table 2) . Three (33%) of nine patients with filter placement noted increased swelling of the legs. No leg swelling was noted after umbrella placement; however, cellulitis developed at the femoral puncture site in one patient (Case 31) and resolved with administration of antibiotics.
Thirteen patients with DVT received anticoagulant agents (Table 3) . Nine had been operated on, and anticoagulation therapy was begun from 8 to 54 days (mean 26 days) postoperatively; 44% of these patients had some complication. Two patients (15%) sustained PE's in spite of anticoagulation levels that were considered adequate by laboratory measurement. One of these (Case 38) died suddenly with clinical symptoms suggesting PE; the other (Case 44) developed a hypercoagulable state with subsequent gangrene of the phlebitic leg, and died from overwhelming sepsis. One patient (Case 43) with an unoperated temporal lobe glioblastoma bled into the tumor after 3 days of heparin therapy, 12 hours after discontinuation of anticoagulants. During her course of heparin therapy, the PTT was kept at approximately 50 seconds; on the day that clinical deterioration led to the discovery of an intracranial hematoma, her PTT was 26.8 seconds (within normal range). Eight patients with symptoms of DVT were managed by observation only. In all eight, noninvasive studies (impedance plethysmography and Doppler ultrasound scanning) were negative in the presence of DVT symptoms, and venography was not performed. Six (75%) of these eight patients subsequently developed symptomatic PE proven by pulmonary angiography or autopsy. In this group, three deaths were attributable to PE (proven by pulmonary angiography in one, documented at autopsy in one, and presumed in one with sudden cardiorespiratory arrest).
Pulmonary Embolism
Of the 13 patients with angiographically proven PE, five underwent IVC clipping (Table 4 ) and eight had an umbrella or IVC filter inserted ( Table 5 ). Three of the five patients with IVC clips had symptomatic leg swelling after clipping. Two of the three with IVC umbrella placement had leg swelling. One patient was given anticoagulants. There were no hemorrhages, deaths, or recurrent PE's in this group.
Morbidity
Inferior vena cava clipping was carried out in 19 patients, with no recurrent PE's; however, nine of these (47%) had significant postoperative leg swelling. A Kim-Ray Greenfield filter was placed in 14 patients, of whom 3 (21%) had significant leg edema. A MobinUddin umbrella was placed in eight patients; two (25 %) of whom noted significant leg edema. No recurrent emboli were found in either the filter or the umbrella treatment group. The difference in the incidence of leg swelling between IVC clipping and filter placement was Anticoagulation alone was used in 13 patients. Four patients (29%) had complications, two of which were fatal.
Discussion
The primary goal of management in cases of DVT and PE is to prevent lethal PE. Secondary objectives are to reestablish deep venous circulation, to relieve symptomatic leg swelling, and to minimize the longterm sequelae of venous flow incompetence. The literature regarding methods of detecting and preventing DVT and PE in neurosurgical patients has been reviewed recently. 23 Thrombi confined to the tibial or superficial calf veins rarely cause significant pulmonary emboli until they cross the popliteal space. 15 Ultrasound 2~ and impedance plethysmography 29 are the most commonly used screening techniques to detect proximal thigh thrombi. Clots located proximally within the iliofemoral system are more likely to be a source of significant PE 15 and thus require more specific therapy. In most nonneurosurgical patients this may be accomplished with anticoagulation therapy. Neurosurgical patients may, however, represent exceptions to the standard treatment because of the potentially disastrous consequences of iatrogenic hemorrhage within the central nervous system.
While there is evidence that prophylactic mini-dose heparin (5000 U subcutaneously twice daily) may be safely used in postoperative neurosurgical patients, 4 a recent report by Di Ricco, et al., 9 stated that nine of 21 neurosurgical patients sustained hemorrhagic complications during therapeutic anticoagulation for PE. Two hemorrhages were encountered at the operative site and seven were in the retroperitoneum, stomach, and bladder. In their series, 9 anticoagulation was used as early as 2 days and as late as 55 days after surgery. The two operative site hemorrhages occurred in patients whose anticoagulation therapy began on the 2nd and 5th postoperative days. These workers 9 advocate anticoagulation in neurosurgical patients with PE even though their data suggest that it may be unsafe in the early postoperative period.
Hemorrhage during heparin therapy appears unpredictably in spite of close laboratory monitoring 27 and occurs with particular frequency in women over 60 years of age. 26 In our anticoagulation therapy group, only one patient suffered a hemorrhage (Case 43); she had an unoperated temporal lobe glioblastoma. The hemorrhage resulted in progressive obtundation which was reversed by clot evacuation and subtotal tumor resection via craniotomy. At the time the hemorrhage became clinically manifest, the patient was normotensive and anticoagulation drugs had been discontinued 12 hours previously in anticipation of insertion of an IVC filter; the PTT was in the normal range.
In this regard, Stern 22 has recommended waiting at least 5 days after craniotomy before proceeding with anticoagulation. We are aware of no study in the recent literature that conclusively demonstrates the safety of and provides a paradigm for timing of full anticoagulation in pre-or postoperative neurosurgical patients. We have, in general, waited 3 weeks before using anticoagulant therapy in patients who have undergone craniotomy and develop DVT or PE. If there is residual tumor into which a hemorrhage might flow, we avoid anticoagulation altogether. Concern over the possibility of hemorrhage in patients with recent operations has led us in most cases to use partial interruption of the IVC to prevent PE. A number of techniques have been described in the literature, including plication or clipping of the IVC and placement of a filter within it. Acute total occlusion of the IVC by surgical ligation carries a mortality rate of 13% and can lead to significant hypotension due to poor venous return. ~6 Suture plication of the IVC was utilized until it was discovered that the channels between sutures can dilate and allow passage of thrombus.13 Problems such as these have led to the development of alternative methods of IVC interruption.
Adams and De Weese ~ devised a plastic clip that is applied transabdominally and separates the IVC into K. W. Swann, P. McL. Black and M. F. Baker four or five channels, trapping emboli larger than 3 mm. Blumenberg and Gelfand 5 reported that the clip had a patency rate of 85% at 6 months and was associated with a 4% incidence of recurrent PE? A significant increase in leg swelling after clipping was noted in 21% of patients in one series: t~ in our experience the figure is 47%. Such swelling may portend later difficulty with chronic venous stasis.
Two devices that are placed transvenously to prevent PE are generally available: the Kim-Ray Greenfield filter and the Mobin-Uddin umbrella. Both are usually inserted via the internal jugular vein, although the Greenfield filter may be introduced transfemorally. The rate of PE in spite of the procedure has been reported to be 2% to 3% for the Greenfield filter 6"tj and 2.5% to 12% for the Mobin-Uddin umbrella. 2'z8 In one series, leg edema occurred after filter placement in 38% of patients with the Greenfield device and in 75% with the Mobin-Uddin umbrella. 3~ Our data suggest a substantially lower figure, in the 21% to 25% range. Perforation of the vena cava has been reported with both devices. 2o,3o
In our series, leg swelling occurred in 47% of patients treated with the IVC clip, in 75% with femoral vein ligations, in 21% with filters, and in 25% with umbrellas. No swelling occurred in patients who received anticoagulants. Swelling was managed with rest and leg elevation and generally was self-limited, although there were several instances of persistent pain and swelling that were very difficult to ameliorate. Anticoagulation was used in one patient with refractory swelling. Severe leg swelling resulted in a gangrenous foot in one patient. Because the Kim-Ray Greenfield filter and the MobinUddin umbrella can be inserted transvenously under local anesthesia and because they are associated with a lower incidence of symptomatic leg swelling, they have been used in this institution for patients who cannot undergo anticoagulation.
Pulmonary embolism occurred in two of our 13 patients who were given anticoagulants for symptomatic DVT. One patient who had undergone bilateral femoral vein ligation subsequently had a PE. There were no PE's after placement of an IVC clip, filter, or umbrella. A high rate of PE and death was found in patients who were managed by observation only after manifesting symptoms of DVT. Of eight patients managed expectantly, six developed symptomatic PE and three died of proven or suspected PE. This mode of management places the patient at obvious risk for the development of serious complications and cannot be recommended.
Thrombolytic agents such as urokinase and streptokinase are used in some centers to lyse pulmonary emboli. 24 We have had no experience with their use in neurosurgical patients. Neither. agent is recommended for administration to neurosurgical patients within 2 months of intracranial surgeryJ 9 Furthermore, both intracerebral hemorrhage and infarction have been reported subsequent to streptokinase infusion?
